Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Tunis Med ; 97(1): 113-121, 2019 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-31535702

RESUMO

INTRODUCTION:   The quality of chronic anticoagulation and predictor factors of poor anticoagulant control in patients under acenocoumarol were unknown in North Africa. METHODS: It is an observational study, carried out between November 2015 and November 30, 2016. The international normalized ratio (INR) values were prospectively obtained, and TTR was calculated using the Rosendaal method. RESULTS: Overall, 215 patients were included in this study, with a mean age of 63±0,8 years. The prevalence of poor anticoagulation control was 78.1%; 95% CI [72.2-83.2] (168 patients with TTR less than 65%). The median TTR with the Rosendaal method was 44.4%. After multivariate adjustment, variables significantly associated with adequate anticoagulation level were: history of ischemic stroke (Adjusted OR equal to 4.3, 95% CI: 1.4-12.9), associated prescription of antiplatelet therapy (Adjusted OR equal to 3.5, 95% CI: 1.1-11.2), daily prescribed dose of coumarins less than 6 mg (Adjusted OR equal to 6.4, 95% CI: 1.1- 36) and lower risk of bleeding assessed as HAS-BLED score (Adjusted OR: 0.5, 95% CI: 0.3-0.8). CONCLUSION: The quality of anticoagulation management with VKA among outpatients who received acenocoumarol was suboptimal. Strategies should be undertaken by clinicians and patients to improve the quality of anticoagulation, to address challenges to adverse cardiovascular outcomes in individuals treated with chronic anticoagulation.


Assuntos
4-Hidroxicumarinas/administração & dosagem , 4-Hidroxicumarinas/farmacocinética , Indenos/administração & dosagem , Indenos/farmacocinética , Adesão à Medicação/estatística & dados numéricos , Vitamina K/antagonistas & inibidores , Administração Oral , Adulto , Idoso , Idoso de 80 Anos ou mais , Anticoagulantes/administração & dosagem , Anticoagulantes/farmacocinética , Fibrilação Atrial/tratamento farmacológico , Fibrilação Atrial/epidemiologia , Fibrilação Atrial/metabolismo , Doenças Cardiovasculares/tratamento farmacológico , Doenças Cardiovasculares/epidemiologia , Doenças Cardiovasculares/metabolismo , Monitoramento de Medicamentos/estatística & dados numéricos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Pacientes Ambulatoriais/estatística & dados numéricos , Prevalência , Fatores Socioeconômicos , Tromboembolia/tratamento farmacológico , Tromboembolia/epidemiologia , Tromboembolia/metabolismo , Fatores de Tempo , Resultado do Tratamento , Tunísia/epidemiologia , Vitamina K/administração & dosagem , Vitamina K/farmacocinética
2.
Environ Health Perspect ; 85: 113-7, 1990 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-2384057

RESUMO

The abilities of paraquat, diquat, and nitrofurantoin to undergo cyclic oxidation and reduction with rat microsomal systems have been assessed and compared to that of the potent redox cycler, menadione. Diquat and menadione were found to be potent redox cyclers with comparable abilities to elicit a nonstoichiometric increase in both the consumption of O2 and the oxidation of NADPH, compared to the amounts of substrate added. In contrast, paraquat and nitrofurantoin redox cycled poorly, being an order of magnitude less potent than either diquat or menadione. This was reflected in kinetic studies using lung and liver microsomes, which showed that NADPH-cytochrome P-450 reductase had a lower affinity (Km) for paraquat and nitrofurantoin than for menadione and diquat, although values of Vmax were comparable for all the substrates except nitrofurantoin, which was lower. In order to assess redox cycling of the substrates in an intact lung system, the O2 consumption of rat lung slices was measured in the presence of all four compounds. A small increase in lung slice O2 uptake was observed with paraquat (10(-5) M) in the first 2.5 hr of incubation, possibly because of redox cycling of a high intracellular concentration of paraquat resulting from active accumulation into target cells. This stimulation in O2 uptake was no longer observed when slices were incubated for a longer period or with higher paraquat concentrations (10(-4) M), possibly because of toxic effects in target cells. High concentrations of diquat (10(-5) M) had no effect on O2 consumption of lung slices.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Diquat/metabolismo , Pneumopatias/metabolismo , Nitrofurantoína/metabolismo , Oxirredução/efeitos dos fármacos , Paraquat/metabolismo , Compostos de Piridínio/metabolismo , Animais , Diquat/farmacocinética , Diquat/toxicidade , Pneumopatias/induzido quimicamente , Pneumopatias/enzimologia , Masculino , Microssomos/metabolismo , Nitrofurantoína/farmacocinética , Nitrofurantoína/toxicidade , Consumo de Oxigênio/efeitos dos fármacos , Paraquat/farmacocinética , Paraquat/toxicidade , Ratos , Ratos Endogâmicos , Vitamina K/metabolismo , Vitamina K/farmacocinética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA